Discovery Lead - Women’s Health & Musculoskeletal Biology at Eli Lilly and Company

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Deep understanding of drug discovery
Passion for developing innovative medicines for areas of high unmet medical need
Background in metabolic diseases, women’s health and/or musculoskeletal biology
Track record of identifying novel therapeutic approaches
Experience progressing molecules to the clinic
Experience leading projects in drug discovery and development
Ability to lead a team of 5-15 preclinical biologists
Dynamic and strategic leadership qualities

Responsibilities

Shape Lilly’s strategy in Women’s Health and Age-related Functional Decline by combining deep understanding of biology, current therapeutic landscape, competitive environment, and evaluation of internal/external opportunities to build an industry-leading portfolio
Collaborate with clinical colleagues, new product planning, and senior leadership to set overall program strategy and develop/maintain draft launch labels and value propositions addressing key customer needs
Lead evaluation of external partnership opportunities, make strategic recommendations to leadership, and ensure scientific leadership through execution and management
Build, maintain, and advance a portfolio of projects with potential to transform Women’s Health and address unmet needs in age-related functional decline
Partner closely with bioinformatics to apply computational approaches to target selection and drug discovery
Ensure state-of-the-art biology capabilities in prioritized areas of Women’s Health and Musculoskeletal Biology using internal and external resources
Ensure delivery of quality lead and candidate molecules
Establish and lead partnerships with academic institutions and biotechs to complement internal research efforts
Direct research from target identification through preclinical development and collaborate across disciplines to progress projects through preclinical and clinical portfolio
Effectively represent Lilly in interactions (e.g., with external partners)

Skills

Key technologies and capabilities for this role

drug discoveryportfolio managementwomen's healthmusculoskeletal biologymetabolic diseasesPCOSendometriosispreeclampsiamenopause disordersosteoporosismuscle function decline

Questions & Answers

Common questions about this position

What is the team size this role will lead?

The Discovery Lead will lead a team of 5-15 preclinical biologists.

What specific areas of focus are there for this Discovery Lead role?

Indications of interest include PCOS, endometriosis, preeclampsia, menopause-related disorders, osteoporosis and age-related decline in muscle function.

What experience is required for this position?

The role requires a dynamic and strategic leader with deep understanding of drug discovery, a passion for developing innovative medicines for areas of high unmet medical need, and a background in metabolic diseases, women’s health and/or musculoskeletal biology, along with a track record of identifying novel therapeutic approaches, progressing molecules to the clinic, and leading projects.

What is the company culture like at Eli Lilly?

Eli Lilly unites caring with discovery to make life better for people around the world, putting people first, advancing innovation in areas of high unmet medical need, and contributing to scientific excellence and patient-centered care.

What does Lilly look for in candidates for this Discovery Lead role?

Lilly seeks an experienced discovery leader with expertise in drug discovery, women's health, musculoskeletal biology or metabolic diseases, and a proven track record in advancing projects from target identification to clinical stages.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free